RISK  	RISK  	 NN	B-NP
FACTORS  	FACTORS  	 NN	I-NP
FOR  	FOR  	 IN	I-NP
INTRAVESICAL  	INTRAVESICAL  	 NNP	I-NP
RECURRENCE  	RECURRENCE  	 NNP	I-NP
AFTER  	AFTER  	 NNP	O
SURGICAL  	SURGICAL  	 NNP	B-NP
MANAGEMENT  	MANAGEMENT  	 NNP	I-NP
OF  	OF  	 IN	I-NP
UROTHERIAL  	UROTHERIAL  	 NNP	I-NP
CARCINOMA  	CARCINOMA  	 NNP	I-NP
OF  	OF  	 IN	O
THE  	THE  	 DT	O
UPPER  	UPPER  	 NNP	O
URINARY  	URINARY  	 NNP	B-NP
TRACT  	TRACT  	 NNP	I-NP
To  	To  	 TO	O
identify  	identify  	 VB	O
risk  	risk  	 NN	B-NP
factors  	factors  	 NNS	I-NP
for  	for  	 IN	O
developing  	developing  	 VBG	O
recurrent  	recurrent  	 JJ	O
bladder  	bladder  	 NN	O
cancer  	cancer  	 NN	O
in  	in  	 IN	O
patients  	patients  	 NNS	O
who  	who  	 WP	O
underwent  	underwent  	 VBD	O
surgical  	surgical  	 JJ	B-NP
resection  	resection  	 NN	I-NP
for  	for  	 IN	I-NP
urothelial  	urothelial  	 JJ	I-NP
carcinoma  	carcinoma  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
upper  	upper  	 JJ	O
urinary  	urinary  	 JJ	B-NP
tract 	tract 	 NN	I-NP
.  	.  	 .	O
We  	We  	 PRP	O
retrospectively  	retrospectively  	 VBP	O
analyzed  	analyzed  	 VBN	O
322  	322  	 CD	O
patients  	patients  	 NNS	O
who  	who  	 WP	O
underwent  	underwent  	 VBD	O
surgical  	surgical  	 JJ	B-NP
resection  	resection  	 NN	I-NP
for  	for  	 IN	I-NP
urothelial  	urothelial  	 JJ	I-NP
carcinoma  	carcinoma  	 NN	I-NP
of  	of  	 IN	O
the  	the  	 DT	O
upper  	upper  	 JJ	O
urinary  	urinary  	 JJ	B-NP
tract  	tract  	 NN	I-NP
at  	at  	 IN	O
the  	the  	 DT	O
Jikei  	Jikei  	 NNP	O
University  	University  	 NNP	O
Hospital  	Hospital  	 NNP	O
and  	and  	 CC	O
our  	our  	 PRP$	O
affiliated  	affiliated  	 JJ	O
hospitals  	hospitals  	 NNS	O
between  	between  	 IN	O
January  	January  	 NNP	O
2005  	2005  	 CD	O
and  	and  	 CC	O
July  	July  	 NNP	O
2011 	2011 	 CD	O
.  	.  	 .	O
Univariate  	Univariate  	 NNP	B-NP
and  	and  	 CC	O
multivariate  	multivariate  	 JJ	B-NP
analyses  	analyses  	 NNS	I-NP
by  	by  	 IN	O
using  	using  	 VBG	O
the  	the  	 DT	O
Cox  	Cox  	 NNP	B-NP
proportional  	proportional  	 VBD	I-NP
hazards  	hazards  	 JJ	I-NP
model  	model  	 NN	O
were  	were  	 VBD	O
performed  	performed  	 VBN	O
to  	to  	 TO	O
determine  	determine  	 VB	O
the  	the  	 DT	O
risk  	risk  	 NN	B-NP
factors  	factors  	 NNS	I-NP
for  	for  	 IN	I-NP
intravesical  	intravesical  	 JJ	I-NP
recurrence  	recurrence  	 NN	I-NP
after  	after  	 IN	O
nephroureterectomy  	nephroureterectomy  	 NN	B-NP
in  	in  	 IN	O
these  	these  	 DT	O
322  	322  	 CD	O
patients 	patients 	 NNS	O
.  	.  	 .	O
Of  	Of  	 IN	O
the  	the  	 DT	O
322  	322  	 CD	O
patients 	patients 	 NNS	O
,  	,  	 ,	O
111  	111  	 CD	O
patients  	patients  	 NNS	O
( 	( 	 -LRB-	O
34.5 	34.5 	 CD	O
% 	% 	 NN	O
)  	)  	 -RRB-	O
developed  	developed  	 VBD	O
recurrent  	recurrent  	 JJ	O
bladder  	bladder  	 NN	O
cancer  	cancer  	 NN	O
after  	after  	 IN	O
a  	a  	 DT	O
median  	median  	 JJ	B-NP
interval  	interval  	 NN	I-NP
of  	of  	 IN	O
8.0  	8.0  	 CD	O
months 	months 	 NNS	O
.  	.  	 .	O
On  	On  	 IN	O
multivariate  	multivariate  	 JJ	B-NP
analysis 	analysis 	 NN	I-NP
,  	,  	 ,	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
superficial  	superficial  	 JJ	B-NP
tumor  	tumor  	 NN	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
ureteral  	ureteral  	 JJ	B-NP
tumor  	tumor  	 NN	I-NP
were  	were  	 VBD	O
independent  	independent  	 JJ	O
predictors  	predictors  	 NN	O
for  	for  	 IN	O
intravesical  	intravesical  	 JJ	B-NP
recurrence 	recurrence 	 NN	I-NP
.  	.  	 .	O
The  	The  	 DT	O
risk  	risk  	 NN	B-NP
factors  	factors  	 NNS	I-NP
for  	for  	 IN	O
developing  	developing  	 VBG	O
recurrent  	recurrent  	 JJ	O
bladder  	bladder  	 NN	O
cancer  	cancer  	 NN	O
were  	were  	 VBD	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
superficial  	superficial  	 JJ	B-NP
tumor  	tumor  	 NN	I-NP
and  	and  	 CC	O
the  	the  	 DT	O
presence  	presence  	 NN	O
of  	of  	 IN	O
a  	a  	 DT	O
ureteral  	ureteral  	 JJ	B-NP
tumor 	tumor 	 NN	I-NP
.  	.  	 .	O
Further  	Further  	 JJ	B-NP
investigation  	investigation  	 NN	I-NP
is  	is  	 VBZ	O
required  	required  	 VBN	O
to  	to  	 TO	O
evaluate  	evaluate  	 VB	O
the  	the  	 DT	O
efficacy  	efficacy  	 NN	O
of  	of  	 IN	O
perioperative  	perioperative  	 JJ	B-NP
intravesical  	intravesical  	 JJ	I-NP
therapy  	therapy  	 NN	I-NP
for  	for  	 IN	O
the  	the  	 DT	O
prevention  	prevention  	 NN	O
of  	of  	 IN	O
intravesical  	intravesical  	 JJ	B-NP
recurrence 	recurrence 	 NN	I-NP
.  	.  	 .	O
